Precigen, Inc. Files 8-K on Financials
Ticker: PGEN · Form: 8-K · Filed: Mar 19, 2024 · CIK: 1356090
| Field | Detail |
|---|---|
| Company | Precigen, Inc. (PGEN) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
TL;DR
Precigen dropped an 8-K on March 19th detailing their financial results. Check it out.
AI Summary
Precigen, Inc. filed an 8-K on March 19, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the date of the earliest event reported being March 19, 2024. The company, formerly known as Intrexon Corp, is based in Germantown, Maryland.
Why It Matters
This 8-K filing provides an update on Precigen's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial results and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- Precigen, Inc. (company) — Registrant
- Intrexon Corp (company) — Former company name
- March 19, 2024 (date) — Date of report
- 20374 Seneca Meadows Parkway, Germantown, Maryland 20876 (address) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on Precigen, Inc.'s 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 19, 2024.
What is Precigen, Inc.'s former name?
Precigen, Inc.'s former name was Intrexon Corp.
Where are Precigen, Inc.'s principal executive offices located?
Precigen, Inc.'s principal executive offices are located at 20374 Seneca Meadows Parkway, Germantown, Maryland 20876.
What is the SIC code for Precigen, Inc.?
The Standard Industrial Classification (SIC) code for Precigen, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 479 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-03-19 16:17:23
Filing Documents
- dp208564_8k.htm (8-K) — 23KB
- dp208564_ex9901.htm (EX-99.1) — 79KB
- image_001.jpg (GRAPHIC) — 2KB
- 0000950103-24-004017.txt ( ) — 285KB
- pgen-20240319.xsd (EX-101.SCH) — 3KB
- pgen-20240319_lab.xml (EX-101.LAB) — 33KB
- pgen-20240319_pre.xml (EX-101.PRE) — 22KB
- dp208564_8k_htm.xml (XML) — 3KB
02
Item 2.02. Results of Operations and Financial Condition. Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated March 19, 2024, reporting its financial results for the quarter and year ended December 31, 2023. This information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated March 19, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Precigen, Inc. By: /s/ Donald P. Lehr Donald P. Lehr Chief Legal Officer Dated: March 19, 2024